Search results
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 6 days agoAfter more than 13 billion COVID vaccines given around the world, the largest studies to date point...
British patients test world’s first personalised MRNA cancer jab for melanoma
The Independent via Yahoo News· 5 days agoThe “gamechanger” jab works by telling the body to hunt down cancer cells to prevent the deadly...
mRNA Is Promising A Breakthrough In Fighting Cancer - Pfizer (NYSE:PFE)
Benzinga· 1 day agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered....
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 1 day agoNovavax The COVID-19 vaccine market helped companies such as Moderna and Pfizer generate tens of...
Moderna Investors Should Beware Patent-Dispute Fallout (NASDAQ:ABUS)
Seeking Alpha· 7 days agoModerna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 6 days agoThe most recent mRNA failure was a phase 1 trial of Moderna’s mRNA human immunodeficiency virus (HIV) injection. "We are taking this very seriously," Carl Dieffenbach, head ...
U.K. Tests World-First Personalized Skin Cancer Vaccine
Forbes· 4 days agoPersonalized with genetic information from a patient’s own tumor, vaccines like this could one day...
Nasdaq Bull Market: Here's the Best Investing Move You Can Make Right Now
Motley Fool via Yahoo Finance· 1 day agoOther companies, like Amazon, through its Amazon Web Services (AWS) business, sell AI platforms to...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 1 day agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...